INTRODUCTION
Glycogen storage diseases ( G S D s ) a r e a g r o u p o f inherited metabolic disorders characterized by accumulation of abnormal glycogen in muscle or liver or both. More than 10 types of GSD have been described, each caused by a specific enzyme defect. Symptoms include hypoglycaemia, lactate acidosis, muscle weakness, convulsions, growth retardation and hepatomegaly. Type and severity of symptoms depend on whether gluconeogenesis, glycogenolysis or both are disturbed and whether muscle, liver or both tissues are affected. A diagnosis of GSD is almost always made at a young age due to fasting intolerance. In general, symptoms decrease in severity with age.
Hepatocellular carcinoma (HCC) has been documented in GSD types I, III, IV and VI as a complication of the development of cirrhosis or malignant degeneration of liver adenomas. In GSD type I hepatocellular adenomas develop in 22-75% of patients [1] [2] [3] . In rare instances, adenomas can transform to HCC [1] [2] [3] . There are contradictory data on the role of poor metabolic control in the development of adenomas in GSD type I [4, 5] . In GSD type III adenomas and HCC are not as common. In one study including 16 GSD type III patients, 4 (25%) developed adenomas while none developed HCC [6] . In another study in 45 GSD type III patients, only 2 (4 %) developed HCC and cirrhosis was present in both cases [7] . One of the most recent publications indicated that there are only six patients described in the literature with GSD type III and HCC, all of whom had underlying cirrhosis [7] . All these six patients had significant clinical symptoms associated with GSD, such as hypoglycaemia and seizures. Hepatocellular carcinomas in other GSD types are very rare. There is only a single report of a HCC in GSD type VI [8] and two cases in GSD type IV [9, 10] . 
CASE REPORT
A 63 year old male patient was admitted to the hepatology department for assessment of suitability for liver transplantation in February 2015. He had an intriguing medical history as he reported he had been diagnosed with von Gierke disease (GSD type I) as an infant. Follow-up visits stopped at the age of 12, most likely due to the asymptomatic nature of his disease. Unfortunately we were unable to retrieve the relevant medical records from 1951 to 1963. The patient remembered that he had a large belly (possibly hepatomegaly) as a young child, but denied he ever had symptoms typically seen in GSD type I such as hypoglycaemia, growth retardation or seizures. He had never been on a specific diet. His family history was unremarkable. He worked as a gardener all his adult life without any difficulties. At the age of 59, in 2011, he was admitted to a hospital elsewhere with abdominal pain. He was diagnosed, based on computed tomography (CT) and liver histology, with HCC in liver segment V and multiple liver adenomas. He was referred to our center and discussed in a multi-disciplinary setting, with hepatologists, surgeons and radiologists. Unfortunately no specific attention was given to the possible underlying GSD and to the uncommon finding of liver adenomas. The patient underwent segmental resection of the HCC with uneventful course.
In September 2014 he presented with local recurrence of HCC and was treated with radio frequency ablation (RFA). In November 2014 another HCC was diagnosed in the remnant of segment V together with a lesion suggestive of needle tract seeding (either from the initial biopsy in 2011 or from the more recent RFA) and he underwent another RFA. In February 2015 a third HCC recurrence of 16 mm was diagnosed in segment VI and treated with microwave ablation. Since 2011 the number and size of the liver adenomas have remained stable.
In February 2015 he was evaluated and accepted for liver transplantation. Physical examination was unremarkable except for slight hepatomegaly. There was no evidence of alcoholic liver disease and studies for hepatitis B, C, hemochromatosis and autoimmune disorders were negative. Laboratory results are shown in Table I . His MELD score was 7. The mild phenotype with absence of hypoglycaemia and muscle symptoms made GSD type III, IV, VI or IX possible, but type I highly unlikely. The respective enzyme activities were determined in leucocytes, erythrocytes or liver tissue. Absence of debranching enzyme activity (0 nmol/24h/mg Hb, reference range 8-34) confirmed the diagnosis of GSD type III. Branching enzyme activity (GSD type IV), phosphorylase enzyme in liver tissue (GSD type VI) and phosphorylase kinase activity (GSD type IX) were normal. Genetic testing showed compound heterozygosity for the pathogenic mutations c.16C>Tp.(Gly6*) and c.1013_1014dupAT p.(Pro339Ilefs*11) in the AGL gene. A final diagnosis of GSD type IIIb (liver only) was made considering these mutations in the absence of muscle symptoms, normal plasma CK levels and normal cardiac evaluation. In GSD type III, ingestion of large amounts of simple carbohydrates increases plasma lactate and glucose levels. Therefore, we prescribed a diet with more complex carbohydrates and protein and increased the frequency of the meals, without changing the total daily energy intake [11] .
DISCUSSION
We present the intriguing case of a 63-year old man who was diagnosed with moderate liver fibrosis, hepatocellular adenomas, recurrent HCC and GSD type IIIb. To the best of our knowledge this brings the total of reported patients with HCC and GSD type III to seven, but our patient is the first reported case without cirrhosis and without symptoms related to GSD.
Previously reported cases of GSD type III and HCC are summarized in Table II . Four of the seven patients died within 3-4 months after diagnosis and in one patient HCC was diagnosed at autopsy. Only one patient was successfully treated with liver transplantation. All previously reported patients presented with cirrhosis before the occurrence of HCC. Because of these observations, it appears that underlying cirrhosis is a main etiological factor in HCC development in GSD type III, in contrast to the adenoma-carcinoma sequence which is believed to be the primary mechanism in HCC development in GSD type I [12] . However, our patient was only diagnosed with moderate fibrosis (F2). Sampling error is unlikely because of the substantial volume of non-tumorous liver tissue in the wedge resection specimen and absence of clinical, radiological or other evidence to suggest cirrhosis. Therefore, the question arises whether cirrhosis is indeed the dominant factor in the development of HCC in GSD III. Only three cases of GSD type III (with or without HCC) undergoing liver transplantation have been reported [13] . This can be explained by the relatively benign phenotype of GSD type III at older age. Symptoms related to the liver disease typically improve with age and muscle weakness is the most important complaint after the age of 20 in patients with GSD IIIa. Nevertheless, the development of HCC and cirrhosis are very serious, life-threatening complications. Physicians taking care of GSD patients should be aware of this and some form of surveillance for cirrhosis and HCC should be considered.
CONCLUSION
GSD type III is a rare genetic disease, and HCC complicating the disease is even more rare. We present the first patient with asymptomatic GSD type III in whom HCC developed without underlying cirrhosis but in the presence of adenomas. This raises the possibility that in GSD type III, the adenomacarcinoma sequence can occur comparable with observations in GSD type I. Lastly, in the 21st century, with the availability of numerous advanced laboratory, imaging and treatment techniques, listening to patients remains imperative. He knew he had a glycogen storage disease: it took us four years to realize it as well. 
